lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.

about

LncRNA PVT1 promotes malignant progression in squamous cell carcinoma of the head and neck BPLLDA: Predicting lncRNA-Disease Associations Based on Simple Paths With Limited Lengths in a Heterogeneous Network

P2860

Q57493784-4EFF1EE2-656F-4EB8-9A58-1B9FDD3204C5 Q59136386-C095E47B-B908-4DDB-A7BA-8A3F8C4A50DC

P2860

lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.

Item

http://www.wikidata.org/entity/Q47262117

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

lncRNAs PVT1 and HAR1A are pro ...... e for diffuse glioma patients.

@en

lncRNAs PVT1 and HAR1A are pro ...... e for diffuse glioma patients.

@nl

type

Item

label

lncRNAs PVT1 and HAR1A are pro ...... e for diffuse glioma patients.

@en

lncRNAs PVT1 and HAR1A are pro ...... e for diffuse glioma patients.

@nl

prefLabel

lncRNAs PVT1 and HAR1A are pro ...... e for diffuse glioma patients.

@en

lncRNAs PVT1 and HAR1A are pro ...... e for diffuse glioma patients.

@nl

P1476

lncRNAs PVT1 and HAR1A are pro ...... e for diffuse glioma patients.

@en

P2093

Hong-Hao Zhou

http://www.w3.org/2001/XMLSchema#string

Lan-Xiang Wu

http://www.w3.org/2001/XMLSchema#string

Lihua Zhang

http://www.w3.org/2001/XMLSchema#string

Shuang Li

http://www.w3.org/2001/XMLSchema#string

Ying Mei

http://www.w3.org/2001/XMLSchema#string

Yong-Bin Liu

http://www.w3.org/2001/XMLSchema#string

Yonglong Yang

http://www.w3.org/2001/XMLSchema#string

Yu Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

NCBI GEO: archive for functional genomics data sets--update

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease

affy--analysis of Affymetrix GeneChip data at the probe level

Accelerated evolution of nervous system genes in the origin of Homo sapiens

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.

An integrative characterization of recurrent molecular aberrations in glioblastoma genomes.

Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells.

Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer

Upregulation of long noncoding RNA MIAT in aggressive form of chronic lymphocytic leukemias.

P304

78767-78780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20226

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hecun Zou

P577

2017-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29108264

http://www.w3.org/2001/XMLSchema#string

P932

5667997

http://www.w3.org/2001/XMLSchema#string

lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.

about

P2860

P2860

lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932